Page 10 of 12 – SEC Filing
This Amendment No. 4 to the Schedule 13D (this Amendment No. 4) relates to the A ordinary
shares, par value GBP 0.30 per Share (the Shares), of Eros International Plc, an Isle of Man public limited company (the Issuer), and amends the Schedule 13D filed on November 2, 2015 as amended by Amendment
No. 3 thereto filed with the SEC on December 8, 2015, Amendment No. 2 thereto filed with the SEC on December 4, 2015 and Amendment No. 1 thereto filed with the SEC on November 27, 2015 (the Original Schedule
13D and, together with this Amendment No. 4, the Schedule 13D). Capitalized terms used and not defined in this Amendment No. 4 have the meanings set forth in the Original Schedule 13D.
This Amendment No. 4 is being filed to amend Item 2, Item 3, Item 5 and Item 7.
Item 2. Identity and Background
Item 2(a) Individual Reporting Persons of the
Original Schedule 13D is supplementally amended as follows:
Each of the following persons is a member of Daltons management
committee (Daltons Management Committee): James B. Rosenwald III (Mr. Rosenwald), Steven Persky (Mr. Persky), Gifford Combs (Mr. Combs), Belita Ong (Ms. Ong), Arthur Hebert (Mr.
Hebert) and Erin Lavelle (Ms. Lavelle) (such persons collectively being the Dalton Individual Reporting Persons).
Mr. Rosenwald also serves as Chairman and Chief Executive Officer of RCM (in such capacity, the RCM Individual Reporting
Person).
Item 2(c) of the Original Schedule 13D is supplementally amended as follows:
The principal business of each of Dalton and RCM is that of a registered investment adviser engaging in the purchase and sale of investments
for Advisory Clients.
The principal occupation of Mr. Rosenwald is serving in certain capacities for Dalton (including Daltons
Asia Strategy Chief Investment Officer and Co-Chair of Daltons Management Committee) and serving as Chairman and Chief Executive Officer of RCM. The principal occupations of Mr. Persky, Mr. Combs, Ms. Ong, Mr. Hebert and
Ms. Lavelle are serving in certain capacities for Dalton (including serving as members of Daltons Management Committee).
Item 3. Source and Amount of Funds or Other Consideration
Item 3 of the Original Schedule
13D is supplementally amended as follows:
The responses to Item 5 of this Amendment No. 4 are incorporated herein by reference.
Since the filing of Amendment No. 3, the Reporting Persons used working capital of the Advisory Clients to purchase 8,290 Shares for
a total purchase price of $78,792.34 and sold 373,416 Shares including the 116,376 Shares reported herein on Exhibit B (the Sold Shares). The total sale price for the Sold Shares was $4,832,831.07, including brokerage commissions.
Item 5. Interest in Securities of the Issuer
Paragraphs (a)-(b) and (c) of
Item 5 of the Original Schedule 13D are supplementally amended as follows:
The percentages used in this Item 5 and in the rest
of the Schedule 13D are calculated based upon an aggregate of 31,982,488 Shares outstanding on March 31, 2015 as reported in the Issuers Form 20-F/A filed on August 20, 2015.
Follow Eros Stx Global Corporation (NYSE:ESGC)
Follow Eros Stx Global Corporation (NYSE:ESGC)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
This Amendment No. 4 to the Schedule 13D (this Amendment No. 4) relates to the A ordinary
shares, par value GBP 0.30 per Share (the Shares), of Eros International Plc, an Isle of Man public limited company (the Issuer), and amends the Schedule 13D filed on November 2, 2015 as amended by Amendment
No. 3 thereto filed with the SEC on December 8, 2015, Amendment No. 2 thereto filed with the SEC on December 4, 2015 and Amendment No. 1 thereto filed with the SEC on November 27, 2015 (the Original Schedule
13D and, together with this Amendment No. 4, the Schedule 13D). Capitalized terms used and not defined in this Amendment No. 4 have the meanings set forth in the Original Schedule 13D.
This Amendment No. 4 is being filed to amend Item 2, Item 3, Item 5 and Item 7.
| Item 2. | Identity and Background |
Item 2(a) Individual Reporting Persons of the
Original Schedule 13D is supplementally amended as follows:
Each of the following persons is a member of Daltons management
committee (Daltons Management Committee): James B. Rosenwald III (Mr. Rosenwald), Steven Persky (Mr. Persky), Gifford Combs (Mr. Combs), Belita Ong (Ms. Ong), Arthur Hebert (Mr.
Hebert) and Erin Lavelle (Ms. Lavelle) (such persons collectively being the Dalton Individual Reporting Persons).
Mr. Rosenwald also serves as Chairman and Chief Executive Officer of RCM (in such capacity, the RCM Individual Reporting
Person).
Item 2(c) of the Original Schedule 13D is supplementally amended as follows:
The principal business of each of Dalton and RCM is that of a registered investment adviser engaging in the purchase and sale of investments
for Advisory Clients.
The principal occupation of Mr. Rosenwald is serving in certain capacities for Dalton (including Daltons
Asia Strategy Chief Investment Officer and Co-Chair of Daltons Management Committee) and serving as Chairman and Chief Executive Officer of RCM. The principal occupations of Mr. Persky, Mr. Combs, Ms. Ong, Mr. Hebert and
Ms. Lavelle are serving in certain capacities for Dalton (including serving as members of Daltons Management Committee).
| Item 3. | Source and Amount of Funds or Other Consideration |
Item 3 of the Original Schedule
13D is supplementally amended as follows:
The responses to Item 5 of this Amendment No. 4 are incorporated herein by reference.
Since the filing of Amendment No. 3, the Reporting Persons used working capital of the Advisory Clients to purchase 8,290 Shares for
a total purchase price of $78,792.34 and sold 373,416 Shares including the 116,376 Shares reported herein on Exhibit B (the Sold Shares). The total sale price for the Sold Shares was $4,832,831.07, including brokerage commissions.
| Item 5. | Interest in Securities of the Issuer |
Paragraphs (a)-(b) and (c) of
Item 5 of the Original Schedule 13D are supplementally amended as follows:
The percentages used in this Item 5 and in the rest
of the Schedule 13D are calculated based upon an aggregate of 31,982,488 Shares outstanding on March 31, 2015 as reported in the Issuers Form 20-F/A filed on August 20, 2015.
